APA (7th ed.) Citation

Anas Shamsi, Mohd Shahnawaz Khan, Dharmendra Kumar Yadav, Moyad Shahwan, & Moyad Shahwan. (2024). Structure-based screening of FDA-approved drugs identifies potential histone deacetylase 3 repurposed inhibitor: Molecular docking and molecular dynamic simulation approaches. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Anas Shamsi, Mohd Shahnawaz Khan, Dharmendra Kumar Yadav, Moyad Shahwan, and Moyad Shahwan. Structure-based Screening of FDA-approved Drugs Identifies Potential Histone Deacetylase 3 Repurposed Inhibitor: Molecular Docking and Molecular Dynamic Simulation Approaches. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Anas Shamsi, et al. Structure-based Screening of FDA-approved Drugs Identifies Potential Histone Deacetylase 3 Repurposed Inhibitor: Molecular Docking and Molecular Dynamic Simulation Approaches. Frontiers Media S.A., 2024.